Atlas Trials

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Clinical trial NCT06979336 · RECRUITING

Trial details

NCT number
NCT06979336
Sponsor
Genentech, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2025-09-29
Primary completion
2027-08-25
Enrollment
224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.